THIO has gained its generic name and preclinical data on a different form of the cancer drug suggests it could improve ...

MAIA Biotechnology receives USAN Council approval for “ateganosine” as nonproprietary name for anticancer agent THIO: Chicago Friday, March 21, 2025, 14:00 Hrs [IST] MAIA Biot ...

Based upon a successful engagement with the US Food and Drug Administration (FDA) at the End-of-Phase 2 meeting in January 2025, Atea is initiating a global Phase 3 program and expects patient ...

AARISE PHARMACEUTICALS, HARIDWAR (UK) is a fast-growing pharmaceutical company that has made a strong impact in the ...

G-quadruplexes are a unique class of DNA and RNA structures formed by guanosine rich sequences. The main elements of G-quadruplexes are Hoogsteen hydrogen-bonded guanines forming a core of stacking ...